LFB

LFB is a leading biopharmaceutical group that develops, manufactures, and markets medicines for serious and often rare diseases across the therapeutic areas of hemostasis, immunology, and intensive care. As France’s top producer of plasma‑derived medicinal products and the fifth‑largest worldwide, LFB also ranks among Europe’s foremost developers of next‑generation proteins and biotechnology‑based treatments. The company’s strategy is driven by sustained investment in research and development, a strong focus on innovative therapy design, and an expanding international presence, offering expertise in plasma‑derived medications, biologics derived from living sources, and advanced bioproduction services.